15-Aug-2023 Source: Blade Air Mobility
Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), announced financial results for the second quarter ended June 30, 2023.
GAAP QUARTERLY FINANCIAL RESULTS (in thousands except percentages, unaudited) |
||||||||||
Three Months Ended June 30, | ||||||||||
2023 | 2022 | % Change | ||||||||
Revenue | $ | 60,989 | $ | 35,633 | 71.2 | % | ||||
Cost of revenue | 50,620 | 30,522 | 65.8 | % | ||||||
Software development | 1,440 | 1,062 | 35.6 | % | ||||||
General and administrative | 18,410 | 12,144 | 51.6 | % | ||||||
Selling and marketing | 2,728 | 1,638 | 66.5 | % | ||||||
Total Operating Expenses | 73,198 | 45,366 | 61.3 | % | ||||||
Loss from operations | (12,209 | ) | (9,733 | ) | 25.4 | % | ||||
Net (loss) income | $ | (12,232 | ) | $ | 8,412 | NM* | ||||
Passenger net (loss) income | $ | (3,837 | ) | $ | (2,326 | ) | 65.0 | % | ||
Medical net (loss) income | $ | (497 | ) | $ | 694 | NM* | ||||
Unallocated corporate expenses and software development | $ | (7,875 | ) | $ | (8,101 | ) | (2.8 | )% | ||
*Percentage not meaningful |
NON-GAAP(1) QUARTERLY FINANCIAL RESULTS (in thousands except percentages, unaudited) |
||||||||||
Three Months Ended June 30, | ||||||||||
2023 | 2022 | Change | ||||||||
GAAP Revenue | $ | 60,989 | $ | 35,633 | 71.2 | % | ||||
GAAP Cost of revenue | 50,620 | 30,522 | 65.8 | % | ||||||
Flight Profit | 10,369 | 5,111 | 102.9 | % | ||||||
Flight Margin | 17.0 | % | 14.3 | % | +266bps | |||||
Adjusted Corporate Expense | 14,817 | 11,230 | 31.9 | % | ||||||
Adjusted Corporate Expense as a percentage of Revenue | 24.3 | % | 31.5 | % | -720bps | |||||
Adjusted EBITDA | $ | (4,448 | ) | $ | (6,119 | ) | (27.3 | )% | ||
Adjusted EBITDA as a percentage of Revenue | (7.3 | )% | (17.2 | )% | +990bps | |||||
Passenger Adjusted EBITDA | $ | (2,075 | ) | $ | (1,085 | ) | 91.2 | % | ||
Medical Adjusted EBITDA | $ | 3,023 | $ | 1,113 | 171.6 | % | ||||
Adjusted unallocated corporate expenses and software development | $ | (5,396 | ) | $ | (6,147 | ) | (12.2 | )% |
“Blade’s record performance this quarter illustrates the value proposition of our diversified business model,” said Rob Wiesenthal, Blade’s Chief Executive Officer. “In MediMobility Organ Transport, we continue to benefit from new organ preservation technologies that are expanding the market, as well as the addition of a number of new transplant center and organ procurement organizations. In our Passenger business, we saw strong volume and pricing growth in the Northeast, particularly for our 5-minute helicopter transfers between Manhattan and New York area airports.”
“Blade delivered significant year over year improvement in Adjusted EBITDA this quarter, driven by 172% growth in Medical Segment Adjusted EBITDA and cost savings across our corporate platform,” said Will Heyburn, Blade’s Chief Financial Officer. “Our cost efficiency program is showing meaningful results with Adjusted Unallocated Corporate Expenses, which relate to the overall Blade shared services platform, decreasing 12% in Q2 2023 versus the prior year period, despite our significant 71% revenue growth. We expect that continued growth and cost efficiencies will lead to further year over year improvement in Adjusted EBITDA in the second half of the year.”
“The FAA’s blueprint for air mobility, released in July, outlines a gradual transition to Electric Vertical Aircraft, or EVA, utilizing existing air traffic control systems and infrastructure. This approach validates Blade’s unique strategy, focused on our exclusive Blade terminals at existing heliports and airports in the most active air mobility corridors operating around the world today,” stated Melissa Tomkiel, Blade’s President. “As a result, Blade is best positioned to enable the gradual transition of today’s air mobility fliers from helicopters to EVA, which we expect to expand the addressable market for our Passenger segment through lower cost, emission-free, and near-silent flight.”
Second Quarter Ended June 30, 2023 Financial Highlights
Business Highlights and Recent Updates
____________________
(1) See “Use of Non-GAAP Financial Measures” attached to this release for further detail on adjustments to GAAP financial measures.
Conference Call
The Company will conduct a conference call starting at 8:00 a.m. ET on Wednesday, August 9, 2023 to discuss the results for the second quarter ended June 30, 2023.
A live audio-only webcast of the call may be accessed from the Investor Relations section of the Company’s website at https://ir.blade.com/. An archived replay of the call will be available on the Investor Relations section of the Company’s website for one year.
Use of Non-GAAP Financial Information
Blade believes that the non-GAAP measures discussed below, viewed in addition to and not in lieu of our reported U.S. Generally Accepted Accounting Principles (“GAAP”) results, provide useful information to investors by providing a more focused measure of operating results, enhance the overall understanding of past financial performance and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making. The non-GAAP measures presented herein may not be comparable to similarly titled measures presented by other companies. Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Unallocated Corporate Expenses, Corporate Expenses, Adjusted Corporate Expenses, Flight Profit, Flight Margin and Pro forma revenue have been reconciled to the nearest GAAP measure in the tables within this press release.
Adjusted EBITDA and Segment Adjusted EBITDA – Blade reports Adjusted EBITDA, which is a non-GAAP financial measure. This measure excludes non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management does not believe are reflective of our ongoing core operations (as shown in the table below). Blade defines Segment Adjusted EBITDA as segment net income (loss) excluding non-cash items or certain transactions that management does not believe are reflective of our ongoing core operations.
Adjusted Unallocated Corporate Expenses – Blade defines Adjusted Unallocated Corporate Expenses as segment net loss attributable to our Corporate expenses and software development operating segment less non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management does not believe are reflective of our ongoing core operations that cannot be allocated to either of our reporting segments. Adjusted Unallocated Corporate Expenses has the same meaning as Segment Adjusted EBITDA for our Corporate expenses and software development operating segment and is reconciled in the tables below under the caption “Reconciliation of Segment Net Income (loss) to Segment Adjusted EBITDA.”
Constant currency – The unaudited interim condensed consolidated financial statements included here are presented in U.S. dollars. However, Blade’s international operations give rise to fluctuations in foreign exchange rates. To compare results between periods as if exchange rates had remained constant period-over-period and allow change in revenue to be evaluated without the impact of foreign currency exchange rate fluctuations, Blade has included results in constant currency. These are calculated by applying the current period exchange rates to local currency reported results for both the current and prior year.
Corporate Expenses and Adjusted Corporate Expenses – Blade defines Corporate Expenses as total operating expenses excluding cost of revenue. Blade defines Adjusted Corporate Expenses as Corporate Expenses excluding non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management does not believe are reflective of our ongoing core operations.
Flight Profit and Flight Margin – Blade defines Flight Profit as revenue less cost of revenue. Cost of revenue consists of flight costs paid to operators of aircraft and cars, landing fees, right-of-use (“ROU”) asset amortization and internal costs incurred in generating ground transportation revenue using the Company’s owned cars. Blade defines Flight Margin for a period as Flight Profit for the period divided by revenue for the same period. Blade believes that Flight Profit and Flight Margin provide a more accurate measure of the profitability of the Company’s flight and ground operations, as they focus solely on the direct costs associated with those operations.
Pro forma revenue – Pro forma revenue gives effect to revenue from acquisitions that occurred after the commensurate period of the prior year as if they had been acquired on the first day of the commensurate period of the prior year. Pro forma change in revenue is calculated as the difference between the current reported GAAP revenue and the comparative period pro forma revenue. Management believes that discussing pro forma revenue contributes to the understanding of Blade’s performance and trends, because it allows for comparisons of the current year period to that of prior years, normalized for the impact of acquisitions. Management believes that pro forma change in revenue assists in measuring the underlying revenue growth of our business as it stands as of the end of the current year period, which we believe provides insight into our then-current operations. Pro forma change in revenue does not represent organic revenue generated by our business as it stood at the beginning of the prior year period.
Financial Results
BLADE AIR MOBILITY, INC. CONDENSEDCONSOLIDATED BALANCE SHEETS (in thousands, except share data, unaudited) |
|||||||
June 30, 2023 |
December 31, 2022 |
||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 37,348 | $ | 43,296 | |||
Restricted cash | 2,045 | 1,127 | |||||
Accounts receivable, net of allowance of $63 and $— at June 30, 2023 and December 31, 2022 | 22,525 | 10,877 | |||||
Short-term investments | 132,342 | 150,740 | |||||
Prepaid expenses and other current assets | 14,710 | 12,086 | |||||
Total current assets | 208,970 | 218,126 | |||||
Non-current assets: | |||||||
Property and equipment, net | 2,909 | 2,037 | |||||
Investment in joint venture | 390 | 390 | |||||
Intangible assets, net | 43,933 | 46,365 | |||||
Goodwill | 39,797 | 39,445 | |||||
Operating right-of-use asset | 23,186 | 17,692 | |||||
Other non-current assets | 998 | 970 | |||||
Total assets | $ | 320,183 | $ | 325,025 | |||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities: | |||||||
Accounts payable and accrued expenses | $ | 14,879 | $ | 16,536 | |||
Deferred revenue | 10,014 | 6,709 | |||||
Operating lease liability, current | 4,380 | 3,362 | |||||
Total current liabilities | 29,273 | 26,607 | |||||
Non-current liabilities: | |||||||
Warrant liability | 8,979 | 7,083 | |||||
Operating lease liability, long-term | 19,833 | 14,970 | |||||
Deferred tax liability | 1,334 | 1,876 | |||||
Total liabilities | 59,419 | 50,536 | |||||
Stockholders’ Equity | |||||||
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at June 30, 2023 and December 31, 2022. No shares issued and outstanding at June 30, 2023 and December 31, 2022. | — | — | |||||
Common stock, $0.0001 par value; 400,000,000 authorized; 73,169,003 and 71,660,617 shares issued at June 30, 2023 and December 31, 2022, respectively. | 7 | 7 | |||||
Additional paid in capital | 383,629 | 375,873 | |||||
Accumulated other comprehensive income | 3,230 | 2,287 | |||||
Accumulated deficit | (126,102 | ) | (103,678 | ) | |||
Total stockholders’ equity | 260,764 | 274,489 | |||||
Total Liabilities and Stockholders’ Equity | $ | 320,183 | $ | 325,025 |
BLADE AIR MOBILITY, INC. CONDENSEDCONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data, unaudited) |
|||||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 | |||||||
Operating expenses | |||||||||||||||
Cost of revenue | 50,620 | 30,522 | 88,727 | 54,229 | |||||||||||
Software development | 1,440 | 1,062 | 2,563 | 1,897 | |||||||||||
General and administrative | 18,410 | 12,144 | 34,667 | 26,122 | |||||||||||
Selling and marketing | 2,728 | 1,638 | 5,339 | 3,438 | |||||||||||
Total operating expenses | 73,198 | 45,366 | 131,296 | 85,686 | |||||||||||
Loss from operations | (12,209 | ) | (9,733 | ) | (25,036 | ) | (23,423 | ) | |||||||
Other non-operating (expense) income | |||||||||||||||
Interest income, net | 2,077 | 455 | 4,031 | 719 | |||||||||||
Change in fair value of warrant liabilities | (2,462 | ) | 19,266 | (1,896 | ) | 21,816 | |||||||||
Realized loss from sales of short-term investments | (14 | ) | (1,576 | ) | (95 | ) | (1,712 | ) | |||||||
Total other non-operating (expense) income | (399 | ) | 18,145 | 2,040 | 20,823 | ||||||||||
(Loss) income before income taxes | (12,608 | ) | 8,412 | (22,996 | ) | (2,600 | ) | ||||||||
Income tax benefit | (376 | ) | — | (572 | ) | — | |||||||||
Net (loss) income | $ | (12,232 | ) | $ | 8,412 | $ | (22,424 | ) | $ | (2,600 | ) | ||||
Net (loss) income per share: | |||||||||||||||
Basic | $ | (0.17 | ) | $ | 0.11 | $ | (0.31 | ) | $ | (0.04 | ) | ||||
Diluted | $ | (0.17 | ) | $ | 0.10 | $ | (0.31 | ) | $ | (0.04 | ) | ||||
Weighted-average number of shares outstanding: | |||||||||||||||
Basic | 73,169,003 | 71,051,523 | 72,584,138 | 70,913,597 | |||||||||||
Diluted | 73,169,003 | 78,497,356 | 72,584,138 | 70,913,597 |
BLADE AIR MOBILITY, INC. CONDENSEDCONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Cash Flows From Operating Activities: | |||||||||||||||
Net (loss) income | $ | (12,232 | ) | $ | 8,412 | $ | (22,424 | ) | $ | (2,600 | ) | ||||
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities: | |||||||||||||||
Depreciation and amortization | 1,810 | 1,155 | 3,462 | 2,300 | |||||||||||
Stock-based compensation | 2,797 | 1,844 | 6,018 | 3,942 | |||||||||||
Change in fair value of warrant liabilities | 2,462 | (19,266 | ) | 1,896 | (21,816 | ) | |||||||||
Realized loss from sales of short-term investments | 14 | 1,576 | 95 | 1,712 | |||||||||||
Realized foreign exchange loss/(gain) | — | — | 5 | (5 | ) | ||||||||||
Accretion of interest income on held-to-maturity securities | (1,638 | ) | — | (3,024 | ) | — | |||||||||
Deferred tax benefit | (376 | ) | — | (572 | ) | — | |||||||||
Loss on disposal of property and equipment | — | 65 | — | 65 | |||||||||||
Changes in operating assets and liabilities: | |||||||||||||||
Prepaid expenses and other current assets | (1,004 | ) | (2,197 | ) | (2,625 | ) | (3,902 | ) | |||||||
Accounts receivable | (6,045 | ) | (3,659 | ) | (11,630 | ) | (4,124 | ) | |||||||
Other non-current assets | 18 | (504 | ) | (24 | ) | (1,152 | ) | ||||||||
Operating right-of-use assets/lease liabilities | 300 | 105 | 377 | 106 | |||||||||||
Accounts payable and accrued expenses | 3,470 | (1,361 | ) | 87 | 1,275 | ||||||||||
Deferred revenue | 2,227 | 2,220 | 3,307 | 2,524 | |||||||||||
Net cash used in operating activities | (8,197 | ) | (11,610 | ) | (25,052 | ) | (21,675 | ) | |||||||
Cash Flows From Investing Activities: | |||||||||||||||
Purchase of property and equipment | (744 | ) | (189 | ) | (1,390 | ) | (626 | ) | |||||||
Purchase of short-term investments | (14 | ) | (188 | ) | (135 | ) | (453 | ) | |||||||
Proceeds from sales of short-term investments | 4,532 | 197,001 | 20,532 | 208,700 | |||||||||||
Purchase of held-to-maturity investments | — | — | (130,145 | ) | — | ||||||||||
Proceeds from maturities of held-to-maturity investments | — | — | 131,187 | — | |||||||||||
Net cash provided by investing activities | 3,774 | 196,624 | 20,049 | 207,621 | |||||||||||
Cash Flows From Financing Activities: | |||||||||||||||
Proceeds from the exercise of common stock options | — | 58 | 54 | 79 | |||||||||||
Taxes paid related to net share settlement of equity awards | (20 | ) | (1,006 | ) | (101 | ) | (1,011 | ) | |||||||
Net cash used in financing activities | (20 | ) | (948 | ) | (47 | ) | (932 | ) | |||||||
Effect of foreign exchange rate changes on cash balances | 17 | 4 | 20 | 7 | |||||||||||
Net (decrease) increase in cash and cash equivalents and restricted cash | (4,426 | ) | 184,070 | (5,030 | ) | 185,021 | |||||||||
Cash and cash equivalents and restricted cash – beginning | 43,819 | 4,176 | 44,423 | 3,225 | |||||||||||
Cash and cash equivalents and restricted cash – ending | $ | 39,393 | $ | 188,246 | $ | 39,393 | $ | 188,246 | |||||||
Reconciliation to the unaudited interim condensed consolidated balance sheets | |||||||||||||||
Cash and cash equivalents | $ | 37,348 | $ | 186,556 | $ | 37,348 | $ | 186,556 | |||||||
Restricted cash | 2,045 | 1,690 | 2,045 | 1,690 | |||||||||||
Total | $ | 39,393 | $ | 188,246 | $ | 39,393 | $ | 188,246 |
Key Metrics and Non-GAAP Financial Information
BLADE AIR MOBILITY, INC. DISAGGREGATED REVENUE BY PRODUCT LINE (in thousands, unaudited) |
|||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||
Passenger segment | |||||||||||
Short Distance | $ | 19,184 | $ | 10,963 | $ | 29,609 | $ | 15,166 | |||
Jet and Other | 7,406 | 7,421 | 15,485 | 17,173 | |||||||
Total | $ | 26,590 | $ | 18,384 | $ | 45,094 | $ | 32,339 | |||
Medical segment | |||||||||||
MediMobility Organ Transport | $ | 34,399 | $ | 17,249 | 61,166 | 29,924 | |||||
Total | $ | 34,399 | $ | 17,249 | $ | 61,166 | $ | 29,924 | |||
Total Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 |
BLADE AIR MOBILITY, INC. SEGMENT INFORMATION: REVENUE, FLIGHT PROFIT, FLIGHT MARGIN, ADJUSTED EBITDA WITH RECONCILIATION TO TOTAL ADJUSTED EBITDA (in thousands except percentages, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Passenger | $ | 26,590 | $ | 18,384 | $ | 45,094 | $ | 32,339 | |||||||
Medical | 34,399 | 17,249 | 61,166 | 29,924 | |||||||||||
Total Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 | |||||||
Passenger | $ | 4,642 | $ | 2,478 | $ | 7,454 | $ | 3,167 | |||||||
Medical | 5,727 | 2,633 | 10,079 | 4,867 | |||||||||||
Total Flight Profit | $ | 10,369 | $ | 5,111 | $ | 17,533 | $ | 8,034 | |||||||
Passenger | 17.5 | % | 13.5 | % | 16.5 | % | 9.8 | % | |||||||
Medical | 16.6 | % | 15.3 | % | 16.5 | % | 16.3 | % | |||||||
Total Flight Margin | 17.0 | % | 14.3 | % | 16.5 | % | 12.9 | % | |||||||
Passenger | $ | (2,075 | ) | $ | (1,085 | ) | $ | (5,130 | ) | $ | (3,694 | ) | |||
Medical | 3,023 | 1,113 | 4,903 | 2,064 | |||||||||||
Total Segment Adjusted EBITDA | 948 | 28 | (227 | ) | (1,630 | ) | |||||||||
Adjusted unallocated corporate expenses and software development | (5,396 | ) | (6,147 | ) | (11,945 | ) | (12,216 | ) | |||||||
Total Adjusted EBITDA | $ | (4,448 | ) | $ | (6,119 | ) | $ | (12,172 | ) | $ | (13,846 | ) |
BLADE AIR MOBILITY, INC.
RECONCILIATION OF REPORTED REVENUE TO PRO FORMA REVENUE
(in thousands except percentages, unaudited)
The following unaudited pro forma financial information presents what our revenue would have been if the Blade Europe business had been acquired on April 1, 2022 and January 1, 2022 for the three months and six months ended June 30, 2022, respectively. As a result, pro forma revenue includes revenue generated during periods when we did not yet own the acquired business. This unaudited pro forma financial information should not be relied upon as being indicative of the historical results that would have been obtained if the acquisition had occurred on that date, nor the results that may be obtained in the future.
Three Months Ended June 30, | |||||||||||||||
Total | Short Distance | Jet and Other | MediMobility Organ Transport |
||||||||||||
Reported Revenue three months ended June 30, 2022 | $ | 35,633 | $ | 10,963 | $ | 7,421 | $ | 17,249 | |||||||
Impact of Blade Europe | 7,106 | 7,106 | — | — | |||||||||||
Pro forma Revenue | $ | 42,739 | $ | 18,069 | $ | 7,421 | $ | 17,249 | |||||||
Reported Revenue three months ended June 30, 2023 | $ | 60,989 | $ | 19,184 | $ | 7,406 | $ | 34,399 | |||||||
Pro forma change in revenue | 42.7 | % | 6.2 | % | (0.2 | )% | 99.4 | % | |||||||
Impact of foreign currency translation | 0.4 | % | 0.9 | % | ** | ** | |||||||||
Pro forma constant currency change in revenue | 42.3 | % | 5.3 | % | (0.2 | )% | 99.4 | % | |||||||
** Percentage not applicable | |||||||||||||||
Six Months Ended June 30, | |||||||||||||||
Total | Short Distance | Jet and Other | MediMobility Organ Transport |
||||||||||||
Reported Revenue six months ended June 30, 2022 | $ | 62,263 | $ | 15,166 | $ | 17,173 | $ | 29,924 | |||||||
Impact of Blade Europe | 12,400 | 12,400 | — | — | |||||||||||
Pro forma Revenue | $ | 74,663 | $ | 27,566 | $ | 17,173 | $ | 29,924 | |||||||
Reported Revenue three months ended June 30, 2023 | $ | 106,260 | $ | 29,609 | $ | 15,485 | $ | 61,166 | |||||||
Pro forma change in revenue | 42.3 | % | 7.4 | % | (9.8 | )% | 104.4 | % | |||||||
Impact of foreign currency translation | (0.1 | )% | (0.3 | )% | ** | ** | |||||||||
Pro forma constant currency change in revenue | 42.4 | % | 7.7 | % | (9.8 | )% | 104.4 | % | |||||||
** Percentage not applicable |
BLADE AIR MOBILITY, INC. SEATS FLOWN – ALL PASSENGER FLIGHTS (unaudited) |
|||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Seats flown – all passenger flights | 41,637 | 28,241 | 70,187 | 46,735 |
BLADE AIR MOBILITY, INC. REVENUE, FLIGHT PROFIT, FLIGHT MARGIN, ADJUSTED CORPORATE EXPENSES, ADJUSTED EBITDA (in thousands except percentages, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
GAAP Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 | |||||||
GAAP Cost of Revenue | 50,620 | 30,522 | 88,727 | 54,229 | |||||||||||
Flight Profit | 10,369 | 5,111 | 17,533 | 8,034 | |||||||||||
Flight Margin | 17.0 | % | 14.3 | % | 16.5 | % | 12.9 | % | |||||||
Adjusted Corporate Expense | 14,817 | 11,230 | 29,705 | 21,880 | |||||||||||
Adjusted Corporate Expense as a percentage of Revenue | 24.3 | % | 31.5 | % | 28.0 | % | 35.1 | % | |||||||
Adjusted EBITDA | $ | (4,448 | ) | $ | (6,119 | ) | $ | (12,172 | ) | $ | (13,846 | ) | |||
Adjusted EBITDA as a percentage of Revenue | (7.3 | )% | (17.2 | )% | (11.5 | )% | (22.2 | )% |
BLADE AIR MOBILITY, INC. RECONCILIATION OF REVENUE LESS COST OF REVENUE TO FLIGHT PROFIT AND LOSS FROM OPERATIONS (in thousands except percentages, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 | |||||||
Cost of revenue (1) | (50,620 | ) | (30,522 | ) | (88,727 | ) | (54,229 | ) | |||||||
Flight Profit | $ | 10,369 | $ | 5,111 | $ | 17,533 | $ | 8,034 | |||||||
Flight Margin | 17.0 | % | 14.3 | % | 16.5 | % | 12.9 | % | |||||||
Flight Profit | $ | 10,369 | $ | 5,111 | $ | 17,533 | $ | 8,034 | |||||||
Reconciling items: | |||||||||||||||
Software development | (1,440 | ) | (1,062 | ) | (2,563 | ) | (1,897 | ) | |||||||
General and administrative | (18,410 | ) | (12,144 | ) | (34,667 | ) | (26,122 | ) | |||||||
Selling and marketing | (2,728 | ) | (1,638 | ) | (5,339 | ) | (3,438 | ) | |||||||
Loss from operations | $ | (12,209 | ) | $ | (9,733 | ) | $ | (25,036 | ) | $ | (23,423 | ) |
__________
(1) Cost of revenue consists of flight costs paid to operators of aircraft and cars, landing fees, ROU asset amortization and internal costs incurred in generating organ ground transportation revenue using the Company’s owned cars.
BLADE AIR MOBILITY, INC. RECONCILIATION OF TOTAL OPERATING EXPENSES TO ADJUSTED CORPORATE EXPENSES (in thousands except percentages, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Revenue | $ | 60,989 | $ | 35,633 | $ | 106,260 | $ | 62,263 | |||||||
Total operating expenses | 73,198 | 45,366 | 131,296 | 85,686 | |||||||||||
Subtract: | |||||||||||||||
Cost of revenue | 50,620 | 30,522 | 88,727 | 54,229 | |||||||||||
Corporate Expenses | $ | 22,578 | $ | 14,844 | $ | 42,569 | $ | 31,457 | |||||||
Corporate Expenses as percentage of Revenue | 37.0 | % | 41.7 | % | 40.1 | % | 50.5 | % | |||||||
Adjustments to reconcile Corporate Expenses to Adjusted Corporate Expenses | |||||||||||||||
Subtract: | |||||||||||||||
Depreciation and amortization | 1,810 | 1,155 | 3,462 | 2,300 | |||||||||||
Stock-based compensation | 2,797 | 1,844 | 6,018 | 3,942 | |||||||||||
Legal and regulatory advocacy fees (1) | — | 164 | 423 | 1,911 | |||||||||||
Executive severance costs | 119 | — | 265 | — | |||||||||||
SOX readiness costs | 35 | — | 35 | — | |||||||||||
Contingent consideration compensation (earn-out) (2) | 3,000 | — | 2,661 | — | |||||||||||
M&A transaction costs | — | 451 | — | 1,424 | |||||||||||
Adjusted Corporate Expenses | $ | 14,817 | $ | 11,230 | $ | 29,705 | $ | 21,880 | |||||||
Adjusted Corporate Expenses as percentage of Revenue | 24.3 | % | 31.5 | % | 28.0 | % | 35.1 | % |
__________
(1) Represents certain legal and regulatory advocacy fees for matters (primarily the proposed restrictions at East Hampton Airport and the potential operational restrictions on large jet aircraft at Westchester Airport) that we do not consider representative of legal and regulatory advocacy costs that we will incur from time to time in the ordinary course of our business. It is worth noting that we do not anticipate incurring any further legal fees related to the Westchester litigation.
(2) Represents contingent consideration compensation of $3,000 in connection with the Trinity acquisition in respect of 2023 results and a $339 credit recorded in connection with the settlement of the equity-based portion of Trinity’s contingent consideration that was paid in the first quarter of 2023 in respect of 2022 results.
BLADE AIR MOBILITY, INC. RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA (in thousands except percentages, unaudited) |
|||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Net (loss) income | $ | (12,232 | ) | $ | 8,412 | $ | (22,424 | ) | $ | (2,600 | ) | ||||
Depreciation and amortization | 1,810 | 1,155 | 3,462 | 2,300 | |||||||||||
Stock-based compensation | 2,797 | 1,844 | 6,018 | 3,942 | |||||||||||
Change in fair value of warrant liabilities | 2,462 | (19,266 | ) | 1,896 | (21,816 | ) | |||||||||
Realized loss from sales of short-term investments | 14 | 1,576 | 95 | 1,712 | |||||||||||
Interest income, net | (2,077 | ) | (455 | ) | (4,031 | ) | (719 | ) | |||||||
Income tax benefit | (376 | ) | — | (572 | ) | — | |||||||||
Legal and regulatory advocacy fees (1) | — | 164 | 423 | 1,911 | |||||||||||
Executive severance costs | 119 | — | 265 | — | |||||||||||
SOX readiness costs | 35 | — | 35 | — | |||||||||||
Contingent consideration compensation (earn-out) (2) | 3,000 | — | 2,661 | — | |||||||||||
M&A transaction costs | — | 451 | — | 1,424 | |||||||||||
Adjusted EBITDA | $ | (4,448 | ) | $ | (6,119 | ) | $ | (12,172 | ) | $ | (13,846 | ) | |||
Adjusted EBITDA as a percentage of Revenue | (7.3 | )% | (17.2 | )% | (11.5 | )% | (22.2 | )% |
__________
(1) Represents certain legal and regulatory advocacy fees for matters (primarily the proposed restrictions at East Hampton Airport and the potential operational restrictions on large jet aircraft at Westchester Airport) that we do not consider representative of legal and regulatory advocacy costs that we will incur from time to time in the ordinary course of our business. It is worth noting that we do not anticipate incurring any further legal fees related to the Westchester litigation.
(2) Represents contingent consideration compensation of $3,000 in connection with the Trinity acquisition in respect of 2023 results and a $339 credit recorded in connection with the settlement of the equity-based portion of Trinity’s contingent consideration that was paid in the first quarter of 2023 in respect of 2022 results.
BLADE AIR MOBILITY, INC. RECONCILIATION OF SEGMENT NET INCOME (LOSS) TO SEGMENT ADJUSTED EBITDA (in thousands, unaudited) |
|||||||||||||||||||||||
Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | ||||||||||||||||||||||
Passenger | Medical | Unallocated Corporate expenses and software development |
Passenger | Medical | Unallocated Corporate expenses and software development |
||||||||||||||||||
Segment net income (loss) | $ | (3,837 | ) | $ | (497 | ) | $ | (7,898 | ) | $ | (2,326 | ) | $ | 694 | $ | 10,044 | |||||||
Reconciling items: | |||||||||||||||||||||||
Depreciation and amortization | 1,363 | 397 | 50 | 744 | 374 | 37 | |||||||||||||||||
Stock-based compensation | 352 | 123 | 2,322 | 333 | 45 | 1,466 | |||||||||||||||||
Change in fair value of warrant liabilities | — | — | 2,462 | — | — | (19,266 | ) | ||||||||||||||||
Realized loss from sales of short-term investments | — | — | 14 | — | — | 1,576 | |||||||||||||||||
Interest income, net | — | — | (2,077 | ) | — | — | (455 | ) | |||||||||||||||
Income tax benefit | — | — | (376 | ) | — | — | — | ||||||||||||||||
Legal and regulatory advocacy fees (1) | — | — | — | 164 | — | — | |||||||||||||||||
Executive severance costs | 47 | — | 72 | — | — | — | |||||||||||||||||
SOX readiness costs | — | — | 35 | — | — | — | |||||||||||||||||
Contingent consideration compensation (earn-out) (2) | — | 3,000 | — | — | — | — | |||||||||||||||||
M&A transaction costs | — | — | — | — | — | 451 | |||||||||||||||||
Segment Adjusted EBITDA | $ | (2,075 | ) | $ | 3,023 | $ | (5,396 | ) | $ | (1,085 | ) | $ | 1,113 | $ | (6,147 | ) |
Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 | |||||||||||||||||||||
Passenger | Medical | Unallocated Corporate expenses and software development |
Passenger | Medical | Unallocated Corporate expenses and software development |
|||||||||||||||||
Segment net income (loss) | $ | (8,955 | ) | $ | 1,140 | $ | (14,609 | ) | $ | (7,842 | ) | $ | 1,216 | $ | 4,026 | |||||||
Reconciling items: | ||||||||||||||||||||||
Depreciation and amortization | 2,497 | 863 | 102 | 1,478 | 750 | 72 | ||||||||||||||||
Stock-based compensation | 712 | 239 | 5,067 | 759 | 98 | 3,085 | ||||||||||||||||
Change in fair value of warrant liabilities | — | — | 1,896 | — | — | (21,816 | ) | |||||||||||||||
Realized loss from sales of short-term investments | — | — | 95 | — | — | 1,712 | ||||||||||||||||
Interest income, net | — | — | (4,031 | ) | — | — | (719 | ) | ||||||||||||||
Income tax benefit | — | — | (572 | ) | — | — | — | |||||||||||||||
Legal and regulatory advocacy fees (1) | 423 | — | — | 1,911 | — | — | ||||||||||||||||
Executive severance costs | 193 | — | 72 | — | — | — | ||||||||||||||||
SOX readiness costs | — | — | 35 | — | — | — | ||||||||||||||||
Contingent consideration compensation (earn-out) (2) | — | 2,661 | — | — | — | — | ||||||||||||||||
M&A transaction costs | — | — | — | — | — | 1,424 | ||||||||||||||||
Segment Adjusted EBITDA | $ | (5,130 | ) | $ | 4,903 | $ | (11,945 | ) | $ | (3,694 | ) | $ | 2,064 | $ | (12,216 | ) |
______________
(1) Represents certain legal and regulatory advocacy fees for matters (primarily the proposed restrictions at East Hampton Airport and the potential operational restrictions on large jet aircraft at Westchester Airport) that we do not consider representative of legal and regulatory advocacy costs that we will incur from time to time in the ordinary course of our business. It is worth noting that we do not anticipate incurring any further legal fees related to the Westchester litigation.
(2) Represents contingent consideration compensation of $3,000 in connection with the Trinity acquisition in respect of 2023 results and a $339 credit recorded in connection with the settlement of the equity-based portion of Trinity’s contingent consideration that was paid in the first quarter of 2023 in respect of 2022 results.
BLADE AIR MOBILITY, INC. LAST TWELVE MONTHS DISAGGREGATED REVENUE BY PRODUCT LINE (in thousands, unaudited) |
|||||||||||||||
Three Months Ended | |||||||||||||||
Last Twelve Months |
June 30, 2023 |
March 31, 2023 |
December 31, 2022 |
September 30, 2022 |
|||||||||||
Product Line: | |||||||||||||||
Short Distance | $ | 59,429 | $ | 19,184 | $ | 10,425 | $ | 9,418 | $ | 20,402 | |||||
Jet and Other | 27,667 | 7,406 | 8,079 | 7,081 | 5,101 | ||||||||||
MediMobility Organ Transport | 103,021 | 34,399 | 26,767 | 21,636 | 20,219 | ||||||||||
Total Revenue | $ | 190,117 | $ | 60,989 | $ | 45,271 | $ | 38,135 | $ | 45,722 |